|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400084999 |
|
最近更新日期: Date of Last Refreshed on: |
2024-05-29 15:40:04 |
|
注册时间: Date of Registration: |
2024-05-29 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
一项术中冲洗的内镜手术患者保温的随机对照多中心研究 |
|
Public title: |
A randomized controlled multicenter study of warming for patients in endoscopic surgery with Intraoperative flushing |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
一项术中冲洗的内镜手术患者保温的随机对照多中心研究 |
|
Scientific title: |
A randomized controlled multicenter study of warming for patients in endoscopic surgery with Intraoperative flushing |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
田黎丽 |
研究负责人: |
雷迁 |
|
Applicant: |
Lili Tian |
Study leader: |
Lie Qian |
|
申请注册联系人电话: Applicant telephone: |
+86 180 0809 9802 |
研究负责人电话:
Study leader's |
+86 150 1318 9601 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
43376578@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
leiqianggh@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
四川省武侯区双丰西路18号 |
研究负责人通讯地址: |
四川省青羊区一环路西二段32号 |
|
Applicant address: |
18 Shuangfeng Road West, Chengdu, Sichuan, China |
Study leader's address: |
32 Second Section of the First Ring Road West, Chengdu, Sichuan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
四川省医学科学院四川省人民医院 |
||
|
Applicant's institution: |
Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital |
||
|
研究负责人所在单位: |
四川省医学科学院四川省人民医院 |
||
|
Affiliation of the Leader: |
Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023年第568-1号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川省人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Sichuan Academy of Medical Sciences. Ethics Committee of Sichuan People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-01-05 00:00:00 | ||
|
伦理委员会联系人: |
姜梅玲 |
||
|
Contact Name of the ethic committee: |
Jiang Meilin |
||
|
伦理委员会联系地址: |
四川省青羊区一环路西二段32号 |
||
|
Contact Address of the ethic committee: |
32 Second Section of the First Ring Road West, Chengdu, Sichuan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 8739 3318 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
四川省医学科学院四川省人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
四川省青羊区一环路西二段32号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
32 Second Section of the First Ring Road West, Chengdu, Sichuan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-raised |
||||||||||||||||||||||
|
研究疾病: |
围术期低体温患者 |
||||||||||||||||||||||
|
Target disease: |
Perioperative hypothermia |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
1 探讨使用术中冲洗进行内窥镜手术的患者是否会出现体温过低的情况 2 在使用术中冲洗的内窥镜手术中为患者加温的效果如何 3 比较围手术期患者加温和不加温时的术后不良反应和经济影响 |
||||||||||||||||||||||
|
Objectives of Study: |
1 Exploring whether hypothermia occurs in patients undergoing endoscopic surgery with Intraoperative flushing 2 How effective is patient warming during endoscopic surgery with Intraoperative flushing 3 Comparison of patient postoperative adverse reactions and economic effects when patients are warming and not warming in the perioperative period |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1) ≥ 18 岁,男性或女性 (2)择期全身麻醉、椎管内麻醉或神经阻滞麻醉手术;包括经皮前列腺电切术、经尿道输尿管镜检查、膀胱镜检查、经皮肾结石切开术、肩关节镜检查、膝关节镜检查等 (3) 手术时间:≥30min,≤150min (4) 术前体温<37.3°C (5) 术前凝血时间正常 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) ≥18 years old, male or female (2)Elective general anesthesia, intralesional anesthesia, or nerve block anesthesia for surgery; including electrocutaneous prostatectomy, transureteroscopy, cystoscopy, percutaneous nephrolithotomy for renal calculi, shoulder arthroscopy, and knee arthroscopy (3) Surgical time: ≥30min, ≤150min (4) Preoperative temperature <37.3°C (5) Normal preoperative coagulation time |
||||||||||||||||||||||
|
排除标准: |
(1) 精神疾病 (2) 基础体温过高或过低的高/高代谢紊乱患者(中枢性高热患者,包括脑血管疾病、脑外伤和手术、癫痫和急性脑积水引起的中枢性高热;体温调节异常患者,包括恶性高热(MHS)、神经安定恶性综合征,以及明确诊断为甲状腺功能减退或亢进且目前代谢异常的患者); (3) 皮肤屏障受损,如大面积皮肤烧伤 (4) 感染性发热 (5) 其他原因导致手术前三天体温超过 38.5 ℃; (6) 研究者认为不适合参加临床试验的其他人员 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Mental illness (2) Patients with hyper/hypometabolic disorders with high or low basal hypothermia (patients with central hyperthermia including central hyperthermia due to cerebrovascular disease, traumatic brain injury and surgery, epilepsy, and acute hydrocephalus; and thermoregulatory abnormalities including Malignant Hyperthermia (MHS), Neuroleptic Malignant Syndrome, and patients with a clear diagnosis of hypothyroidism or hyperthyroidism who have a current abnormal metabolic profile); (3) Damage to the skin's insulation barrier such as extensive skin burns (4) Infectious fever (5) Other causes of body temperature higher than 38.5 ℃ three days before surgery; (6) Other persons who, in the opinion of the investigator, are not suitable for participation in the clinical trial; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-06-01 00:00:00至 To 2025-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-06-01 00:00:00 至 To 2025-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由统计师通过电脑生成随机数字表 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Generate a random number table by a statistician through a computer |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据收集和管理将采用电子数据管理系统。独立的数据管理委员会和数据监测委员会将对数据的有效性和有效性进行监督。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
An electronic data management system will be employed for data collection and management. Oversight of data validity and effectiveness will be carried out by an independent data management committee and a data monitoring board |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |